Cargando…
Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy
In radiotherapy (RT) of prostate cancer, dose escalation has been shown to reduce biochemical failure. Dose escalation only to determinate prostate tumor habitats has the potential to improve tumor control with less toxicity than when the entire prostate is dose escalated. Other issues in the treatm...
Autores principales: | Yang, Fei, Ford, John C., Dogan, Nesrin, Padgett, Kyle R., Breto, Adrian L., Abramowitz, Matthew C., Dal Pra, Alan, Pollack, Alan, Stoyanova, Radka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043736/ https://www.ncbi.nlm.nih.gov/pubmed/30050803 http://dx.doi.org/10.21037/tau.2018.06.05 |
Ejemplares similares
-
Contemporary role of postoperative radiotherapy for prostate cancer
por: Dal Pra, Alan, et al.
Publicado: (2018) -
Cone-beam CT delta-radiomics to predict genitourinary toxicities and international prostate symptom of prostate cancer patients: a pilot study
por: Delgadillo, Rodrigo, et al.
Publicado: (2022) -
Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy
por: Algohary, Ahmad, et al.
Publicado: (2022) -
Validation of a deformable MRI to CT registration algorithm employing same day planning MRI for surrogate analysis
por: Padgett, Kyle R., et al.
Publicado: (2018) -
Assessment of Knowledge-Based Planning for Prostate Intensity Modulated Proton Therapy
por: Xu, Yihang, et al.
Publicado: (2021)